Back to Search
Start Over
Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
- Source :
- Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- Publication Year :
- 2019
- Publisher :
- Dove Press, 2019.
-
Abstract
- A substantial share of type 2 diabetes mellitus (T2DM) patients receive insulin. However, little is known about the real-world treatment patterns around insulin initiation.This was a retrospective claims data analysis. T2DM patients who initiated an insulin therapy between 01/01/2013 and 31/12/2015 were identified in the German AOK PLUS dataset. For validation of results, additional data on a similar T2DM patient population were collected in a Germany-wide medical chart review.A total of 284,878 T2DM patients were identified. Of these, 27,340 (9.6%) initiated an insulin treatment during the inclusion period (mean age: 72.2 years; 51.4% female). Mean/median weight and BMI of patients with available clinical data was 85.8/84.0 kg (SD:18.9) and 30.6/29.8 kg/mCharacteristics of German T2DM patients initiating insulin deviate substantially from the average German population, especially in terms of weight. We identified an unexpectedly high number of patients without previous AD therapy receiving insulin monotherapy, which is not in line with the clinical guidelines.
Details
- Language :
- English
- ISSN :
- 11787007
- Database :
- OpenAIRE
- Journal :
- Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- Accession number :
- edsair.doi.dedup.....56efaa55ad68fac87b850a77778c58b8